Tanshinone IIA reduces SW837 colorectal cancer cell viability via the promotion of mitochondrial fission by activating JNK-Mff signaling pathways
S Jieensinue, H Zhu, G Li, K Dong, M Liang, Y Li - BMC cell biology, 2018 - Springer
Background Mitochondrial homeostasis has been increasingly viewed as a potential target
of cancer therapy, and mitochondrial fission is a novel regulator of mitochondrial function …
of cancer therapy, and mitochondrial fission is a novel regulator of mitochondrial function …
Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt/mTOR pathway
L Vucicevic, M Misirkic, J Kristina, U Vilimanovich… - Autophagy, 2011 - Taylor & Francis
In the present study, we report that compound C, an inhibitor of a key intracellular energy
sensor AMP-activated protein kinase (AMPK), can induce autophagy in cancer cells. The …
sensor AMP-activated protein kinase (AMPK), can induce autophagy in cancer cells. The …
Mitochondrial dysfunction in breast cancer cells prevents tumor growth: understanding chemoprevention with metformin
R Sanchez-Alvarez, UE Martinez-Outschoorn, R Lamb… - Cell Cycle, 2013 - Taylor & Francis
Metformin is a well-established diabetes drug that prevents the onset of most types of human
cancers in diabetic patients, especially by targeting cancer stem cells. Metformin exerts its …
cancers in diabetic patients, especially by targeting cancer stem cells. Metformin exerts its …
Mitocans revisited: mitochondrial targeting as efficient anti-cancer therapy
Mitochondria are essential cellular organelles, controlling multiple signalling pathways
critical for cell survival and cell death. Increasing evidence suggests that mitochondrial …
critical for cell survival and cell death. Increasing evidence suggests that mitochondrial …
[HTML][HTML] Onconase induces autophagy sensitizing pancreatic cancer cells to gemcitabine and activates Akt/mTOR pathway in a ROS-dependent manner
Onconase®(ONC) is a member of the RNase super-family that is secreted in oocytes and
early embryos of Rana pipiens. Over the last years, research interest about this small and …
early embryos of Rana pipiens. Over the last years, research interest about this small and …
[HTML][HTML] Mitochondria in colorectal cancer stem cells-a target in drug resistance
M de Almeida Rainho, PB Siqueira… - Cancer Drug …, 2023 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is the third most diagnosed cancer and the second most deadly
type of cancer worldwide. In late diagnosis, CRC can resist therapy regimens in which …
type of cancer worldwide. In late diagnosis, CRC can resist therapy regimens in which …
[PDF][PDF] Targeting tumor mitochondrial metabolism overcomes resistance to antiangiogenics
Epithelial malignancies are effectively treated by antiangiogenics; however, acquired
resistance is a major problem in cancer therapeutics. Epithelial tumors commonly have …
resistance is a major problem in cancer therapeutics. Epithelial tumors commonly have …
Aloe gel glucomannan induced colon cancer cell death via mitochondrial damage-driven PINK1/Parkin mitophagy pathway
K Zhang, D Zhang, J Wang, Y Wang, J Hu, Y Zhou… - Carbohydrate …, 2022 - Elsevier
Mitophagy can selectively remove damaged mitochondria, which is critical in regulating
mitochondrial homeostasis in diseases, such as cancer. Herein, we found that Aloe gel …
mitochondrial homeostasis in diseases, such as cancer. Herein, we found that Aloe gel …
Selection of cancer cells with repressed mitochondria triggers colon cancer progression
M Sánchez-Aragó, M Chamorro, JM Cuezva - Carcinogenesis, 2010 - academic.oup.com
The contribution that mitochondrial bioenergetics could have in cancer development is
debated. Here, we have generated HCT116-derived colocarcinoma cell lines expressing …
debated. Here, we have generated HCT116-derived colocarcinoma cell lines expressing …
Exploiting mitochondrial vulnerabilities to trigger apoptosis selectively in cancer cells
C Nguyen, S Pandey - Cancers, 2019 - mdpi.com
The transformation of normal cells to the cancerous stage involves multiple genetic changes
or mutations leading to hyperproliferation, resistance to apoptosis, and evasion of the host …
or mutations leading to hyperproliferation, resistance to apoptosis, and evasion of the host …